David Gandara: Joel W. Neal on targeted therapies at WCLC24

David Gandara shared a post on X:

“Best of WCLC24 in San Francisco.

Joel W. Neal, ‘Sets the Stage’ for the session on targeted therapies.

Fabulous conference highlighting important abstracts from our recent IASLC WCLC.”

Source: David Gandara/X

David Gandara is the Co-Director-Center for Experimental Therapeutics and a professor at UC Davis Comprehensive Cancer Center. His research interests focus on developmental therapeutics of new anti-cancer agents as well as preclinical modeling and clinical research in lung cancer.